SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
76.72    1.92 (2.57%)
Bid:
76.70
Ask:
76.76
Spread: 0.06 (0.078%)
Market Cap: £2.66b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

9 Nov 2023 07:00

RNS Number : 8659S
Taylor Wimpey PLC
09 November 2023
 

 

9 November 2023

Taylor Wimpey plc

Trading statement

 

Resilient performance, expect to deliver full year profit at top end of guidance

Jennie Daly, CEO, commented:

"Taylor Wimpey has delivered a resilient performance in what continues to be a challenging market backdrop, reporting a robust sales rate and strong financial position, and reiterating our full year 2023 UK volume guidance in the range of 10,000 to 10,500 homes. Due to our focus on optimising price and sharp cost discipline, we now expect Group operating profit* to be at the top end of our guidance range of £440 million to £470 million. This performance is testament to the hard work of our experienced teams, who have continued to adapt and support customers through their buying journey while being focused on delivering efficiencies across the business.

Taylor Wimpey is a strong, sustainable and agile business underpinned by a robust balance sheet and an excellent well-located landbank. These attributes ensure we are well positioned to manage the business and optimise performance in all market conditions, delivering quality homes to our customers and long term growth and value to our stakeholders.

Looking ahead, while the market backdrop remains uncertain, we are confident in the medium to long term sector fundamentals, with a meaningful supply and demand imbalance in UK housing."

 

UK trading

The market continues to be impacted by weak consumer confidence influenced by high mortgage rates and cost of living pressures which are negatively affecting affordability for our customers. However, we have attractive and resilient locations which, combined with our enhanced customer and marketing tools, has enabled us to deliver a good performance against a challenging backdrop.

In the second half to date, our net private sales rate per outlet per week was 0.51 (2022: 0.51) with a cancellation rate of 21% (2022: 24%). Excluding the impact of bulk deals, we achieved a net private sales rate of 0.48 for the second half to date (2022: 0.50).

For the year to date, we achieved a net private sales rate of 0.63 (2022: 0.74), with a cancellation rate of 18% (2022: 18%). Excluding the impact of bulk deals, we achieved a net private sales rate of 0.57 for the year to date (2022: 0.72).

As at 5 November 2023, our current total order book excluding joint ventures stood at c.£1.9 billion (2022: c.£2.6 billion) representing 7,042 homes (2022: 9,153).

In the year to date, we have operated on an average of 239 sales outlets (2022: 229), and we are currently operating from 227 outlets (2022: 234).

As expected, we have continued to see build cost inflation moderate as the year has progressed.

Optimising performance in a challenging market

Over the last year we have acted decisively and proactively to mitigate risk through the levers available to us. In light of reduced market demand, we have closely controlled costs and our investment in work in progress, with our teams focused on delivering efficiencies across the business.

We continue to be highly selective in our land buying and year to date approvals are c.3k plots.

As at the end of October 2023, our short term landbank stood at c.82k plots (2 July 2023: c.83k) and our strategic land pipeline stood at c.140k potential plots (2 July 2023: c.140k). In the year to date we have converted c.6k plots from our strategic pipeline, a significant number of which were already owned, further limiting land spend.

We have a strong balance sheet and are highly cash generative. We continue to expect to end the year with net cash** between £500 million to £650 million after returning c.£338 million in dividend payments during 2023.

Outlook

We continue to expect to deliver full year 2023 UK volumes in the range of 10,000 to 10,500 homes, and due to our focus on optimising price and sharp cost discipline, we now expect Group operating profit to be at the top end of our guidance range of £440 million to £470 million.

Looking ahead, there remains significant market uncertainty and our focus is on ensuring we remain agile and well positioned to optimise performance in all market conditions, delivering quality homes to our customers and long term growth and value to our stakeholders.

Taylor Wimpey is financially strong with a high-quality, well-located landbank and a highly experienced management team with a focus on protecting value while driving further operational efficiency. We remain confident in the medium to long term sector fundamentals with a continued meaningful supply and demand imbalance in UK housing.

* Operating profit is defined as profit on ordinary activities before financing, exceptional items and tax, after share of results of joint ventures.

** Net cash is defined as total cash less total borrowings.

 

Note:

2022 relates to 2022 equivalent trading period, unless stated.

 

-Ends-

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 8.00am on 9 November 2023. The call will be recorded and streamed live to our website: https://www.taylorwimpey.co.uk/corporate/investors/results-and-reports

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder, operating at a local level from 22 regional businesses across the UK. We also have operations in Spain.

For further information please visit the Group's website: www.taylorwimpey.co.uk/corporate

Follow us on Twitter @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIVLFLTIIV
Date   Source Headline
3rd Mar 20254:33 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:09 pmRNSTotal Voting Rights
28th Feb 20253:28 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
12th Feb 20252:47 pmRNSDirector/PDMR Shareholding
3rd Feb 20252:04 pmRNSTotal Voting Rights
27th Jan 20253:58 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Statement
10th Jan 202510:48 amRNSDirector/PDMR Shareholding
2nd Jan 20251:45 pmRNSBlock listing Interim Review
2nd Jan 20251:42 pmRNSBlock listing Interim Review
2nd Jan 20251:28 pmRNSTotal Voting Rights
19th Dec 20247:31 amRNSTransaction in Own Shares
13th Dec 20243:42 pmRNSDirector/PDMR Shareholding
10th Dec 20244:50 pmRNSDirector/PDMR Shareholding
4th Dec 20245:10 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
26th Nov 20243:22 pmRNSHolding(s) in Company
22nd Nov 202411:09 amRNSDirectorate Change
19th Nov 20243:32 pmRNSDirector/PDMR Shareholding
19th Nov 20243:03 pmRNSHolding(s) in Company
13th Nov 20243:32 pmRNSHolding(s) in Company
11th Nov 20242:58 pmRNSDirector/PDMR Shareholding
11th Nov 20242:39 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSTrading Statement
1st Nov 202410:08 amRNSTotal Voting Rights
9th Oct 20242:00 pmRNSDirector/PDMR Shareholding
1st Oct 20241:26 pmRNSTotal Voting Rights
26th Sep 20242:40 pmRNSDirector/PDMR Shareholding
20th Sep 202412:47 pmRNSHolding(s) in Company
10th Sep 20244:08 pmRNSDirector/PDMR Shareholding
2nd Sep 20243:30 pmRNSTotal Voting Rights
9th Aug 20242:36 pmRNSDirector/PDMR Shareholding
1st Aug 20242:57 pmRNSTotal Voting Rights
31st Jul 20247:05 amRNSBoard Committee Change
31st Jul 20247:00 amRNSHalf year results 2024
26th Jul 20243:22 pmRNSHolding(s) in Company
22nd Jul 20249:10 amRNSHolding(s) in Company
9th Jul 202411:26 amRNSDirector/PDMR Shareholding
1st Jul 20243:12 pmRNSTotal Voting Rights
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:29 amRNSBlock listing Interim Review
17th Jun 20243:18 pmRNSDirector/PDMR Shareholding
6th Jun 202411:22 amRNSHolding(s) in Company
3rd Jun 20249:17 amRNSTotal Voting Rights
30th May 20244:07 pmRNSDirector/PDMR Shareholding
17th May 20247:15 amRNSDirector/PDMR Shareholding
15th May 20241:09 pmRNSDirector/PDMR Shareholding
9th May 202411:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.